Hematopoietic stem cell expansion and generation: The ways to make a breakthrough

Bokyung Park, Keon Hee Yoo, Changsung Kim

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Hematopoietic stem cell transplantation (HSCT) is the first field where human stem celltherapy was successful. Flooding interest on human stem cell therapy to cure previouslyincurable diseases is largely indebted to HSCT success. Allogeneic HSCT has been an importantmodality to cure various diseases including hematologic malignancies, variousnon-malignant hematologic diseases, primary immunodeficiency diseases, and inbornerrors of metabolism, while autologous HSCT is generally performed to rescue bone marrowaplasia following high-dose chemotherapy for solid tumors or multiple myeloma.Recently, HSCs are also spotlighted in the field of regenerative medicine for the ameliorationof symptoms caused by neurodegenerative diseases, heart diseases, and others.Although the demand for HSCs has been growing, their supply often fails to meet thedemand of the patients needing transplant due to a lack of histocompatible donors ora limited cell number. This review focuses on the generation and large-scale expansionof HSCs, which might overcome current limitations in the application of HSCs for clinicaluse. Furthermore, current proof of concept to replenish hematological homeostasis fromnon-hematological origin will be covered.

Original languageEnglish (US)
Pages (from-to)194-203
Number of pages10
JournalBlood Research
Volume50
Issue number4
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells
Regenerative Medicine
Hematologic Diseases
Hematologic Neoplasms
Cell- and Tissue-Based Therapy
Multiple Myeloma
Neurodegenerative Diseases
Heart Diseases
Homeostasis
Stem Cells
Cell Count
Tissue Donors
Transplants
Bone and Bones
Drug Therapy
Neoplasms

Keywords

  • Blood generation
  • HLA
  • HSC expansion
  • HSCT
  • Stem cell

ASJC Scopus subject areas

  • Hematology

Cite this

Hematopoietic stem cell expansion and generation : The ways to make a breakthrough. / Park, Bokyung; Yoo, Keon Hee; Kim, Changsung.

In: Blood Research, Vol. 50, No. 4, 2015, p. 194-203.

Research output: Contribution to journalReview article

Park, Bokyung ; Yoo, Keon Hee ; Kim, Changsung. / Hematopoietic stem cell expansion and generation : The ways to make a breakthrough. In: Blood Research. 2015 ; Vol. 50, No. 4. pp. 194-203.
@article{4058669eb0a148569dd7847a95bd4ea8,
title = "Hematopoietic stem cell expansion and generation: The ways to make a breakthrough",
abstract = "Hematopoietic stem cell transplantation (HSCT) is the first field where human stem celltherapy was successful. Flooding interest on human stem cell therapy to cure previouslyincurable diseases is largely indebted to HSCT success. Allogeneic HSCT has been an importantmodality to cure various diseases including hematologic malignancies, variousnon-malignant hematologic diseases, primary immunodeficiency diseases, and inbornerrors of metabolism, while autologous HSCT is generally performed to rescue bone marrowaplasia following high-dose chemotherapy for solid tumors or multiple myeloma.Recently, HSCs are also spotlighted in the field of regenerative medicine for the ameliorationof symptoms caused by neurodegenerative diseases, heart diseases, and others.Although the demand for HSCs has been growing, their supply often fails to meet thedemand of the patients needing transplant due to a lack of histocompatible donors ora limited cell number. This review focuses on the generation and large-scale expansionof HSCs, which might overcome current limitations in the application of HSCs for clinicaluse. Furthermore, current proof of concept to replenish hematological homeostasis fromnon-hematological origin will be covered.",
keywords = "Blood generation, HLA, HSC expansion, HSCT, Stem cell",
author = "Bokyung Park and Yoo, {Keon Hee} and Changsung Kim",
year = "2015",
doi = "10.5045/br.2015.50.4.194",
language = "English (US)",
volume = "50",
pages = "194--203",
journal = "Blood Research",
issn = "2287-979X",
publisher = "Korean Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Hematopoietic stem cell expansion and generation

T2 - The ways to make a breakthrough

AU - Park, Bokyung

AU - Yoo, Keon Hee

AU - Kim, Changsung

PY - 2015

Y1 - 2015

N2 - Hematopoietic stem cell transplantation (HSCT) is the first field where human stem celltherapy was successful. Flooding interest on human stem cell therapy to cure previouslyincurable diseases is largely indebted to HSCT success. Allogeneic HSCT has been an importantmodality to cure various diseases including hematologic malignancies, variousnon-malignant hematologic diseases, primary immunodeficiency diseases, and inbornerrors of metabolism, while autologous HSCT is generally performed to rescue bone marrowaplasia following high-dose chemotherapy for solid tumors or multiple myeloma.Recently, HSCs are also spotlighted in the field of regenerative medicine for the ameliorationof symptoms caused by neurodegenerative diseases, heart diseases, and others.Although the demand for HSCs has been growing, their supply often fails to meet thedemand of the patients needing transplant due to a lack of histocompatible donors ora limited cell number. This review focuses on the generation and large-scale expansionof HSCs, which might overcome current limitations in the application of HSCs for clinicaluse. Furthermore, current proof of concept to replenish hematological homeostasis fromnon-hematological origin will be covered.

AB - Hematopoietic stem cell transplantation (HSCT) is the first field where human stem celltherapy was successful. Flooding interest on human stem cell therapy to cure previouslyincurable diseases is largely indebted to HSCT success. Allogeneic HSCT has been an importantmodality to cure various diseases including hematologic malignancies, variousnon-malignant hematologic diseases, primary immunodeficiency diseases, and inbornerrors of metabolism, while autologous HSCT is generally performed to rescue bone marrowaplasia following high-dose chemotherapy for solid tumors or multiple myeloma.Recently, HSCs are also spotlighted in the field of regenerative medicine for the ameliorationof symptoms caused by neurodegenerative diseases, heart diseases, and others.Although the demand for HSCs has been growing, their supply often fails to meet thedemand of the patients needing transplant due to a lack of histocompatible donors ora limited cell number. This review focuses on the generation and large-scale expansionof HSCs, which might overcome current limitations in the application of HSCs for clinicaluse. Furthermore, current proof of concept to replenish hematological homeostasis fromnon-hematological origin will be covered.

KW - Blood generation

KW - HLA

KW - HSC expansion

KW - HSCT

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=84951150142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951150142&partnerID=8YFLogxK

U2 - 10.5045/br.2015.50.4.194

DO - 10.5045/br.2015.50.4.194

M3 - Review article

AN - SCOPUS:84951150142

VL - 50

SP - 194

EP - 203

JO - Blood Research

JF - Blood Research

SN - 2287-979X

IS - 4

ER -